"This provestheconcept that GM-SCF, onlyinthe lung, is sufficient toprovidecompleteprotectionagainstinfection with otherwise lethaldoses of influenzavirus strains," saidDr.Shams.
Five patients with a lethal leukemia achieved complete and rapid remissions after the treatment, in which cells from their own immune systems were genetically altered to specifically attack the disease.